Researchers first found antibodies in people who had mpox or who had been vaccinated. The team in Italy identified a set of antibodies in blood samples. A second team at a US university used the AlphaFold 3 AI model to predict which viral surface proteins the antibodies attach to.
The AI predicted that several antibodies bind to a protein called OPG153. Laboratory tests confirmed the prediction. When researchers gave an engineered version of that protein to mice, the animals produced antibodies that neutralized the virus. The finding could lead to a simpler vaccine ingredient or to antibody treatments.
Difficult words
- antibody — molecules the immune system makes to fight infectionantibodies
- vaccinate — give a vaccine to protect from a diseasevaccinated
- predict — say what will happen before it is knownpredicted
- protein — a natural molecule in cells with many jobsproteins
- bind — stick to something tightly or join together
- neutralize — make a virus or poison not able to harmneutralized
Tip: hover, focus or tap highlighted words in the article to see quick definitions while you read or listen.
Discussion questions
- Do you think a simpler vaccine ingredient is a good idea? Why or why not?
- How do you feel about using AI to help find parts for vaccines?
- Have you or someone you know been vaccinated? What was your experience?
Related articles
RSV can cause long-term problems after hospital care
A study found that adults hospitalised with respiratory syncytial virus (RSV) often had lasting problems. Many patients experienced breathlessness and trouble with daily activities for months, and some stayed unwell for up to a year.
Cherry compounds may slow triple-negative breast cancer
Researchers at Texas A&M report that anthocyanins from dark sweet cherries slowed tumour growth and reduced metastasis in mice, and that combining them with chemotherapy helped control tumours. Further research is needed on safety and absorption.
Biosensor reveals cancer-specific vulnerability in PRMT5
Researchers found that a metabolite change in some tumors makes the protein PRMT5 bind MTA instead of SAM. A new NanoBRET biosensor and a probe called CBH-002 measure drug binding to this cancer-specific form of PRMT5 in live cells.
